Contact us for competitive discounts on bulk quantities
Biological Activity:
Deforolimus is an immunosupressant currently undergoing research for the treatment of certain cancers. It is a small-molecule inhibitor of the mammalian target of rapamycin (mTOR).
References:
1.Rivera VM, et al. Ridaforolimus (AP23573; MK8669), a potent mTOR inhibitor, has broad antitumor activity and can be optimally administered using intermittent dosing regimens. Mol Cancer Ther, 2011, 10(6), 1059-1071.
2. Legrier ME, et al. Targeting protein translation in human non small cell lung cancer via combined MEK and mammalian target of rapamycin suppression. Cancer Res, 2007, 67(23), 11300-11308.